The EDQM: ensuring drug quality in the face of globalisation
This article was originally published in SRA
Dr Susanne Keitel, director of the European Directorate for the Quality of Medicines & HealthCare, tells Neena Brizmohun how the European Pharmacopoeia is adapting to meet the challenges it is facing.
You may also be interested in...
The latest list of marketing authorization applications under review by the European Medicines Agency includes filings for eight new products.
Viela and Roche both now have marketing applications that are being reviewed by the European Medicines Agency. If approved in the EU, their products will compete with Alexion’s blockbuster Soliris.
Most of the products currently supplied under Australia’s custom-made medical device exemption will no longer be eligible for supply in this way.